Cancerappy
CancerAppy is a biotech company founded in 2019, specializing in cancer research. They focus on discovering and developing new therapeutic targets using a proprietary artificial intelligence methodology. Their platform analyzes vast amounts of multimodal data with advanced AI algorithms to identify new targets, discover lead compounds, understand mechanisms of action, and explore drug combinations. They also develop next-generation antibody-drug conjugates (ADCs) for more precise cancer treatments. CancerAppy operates in the early stage of the Drug Discovery Value Chain and offers consulting services in areas like target validation, inhibitor identification, and computer-aided drug design. Their mission is to translate scientific discoveries into clinical practice to improve cancer diagnosis and treatment, aiming to become a global reference tool for scientists and drug developers.
Cancerappy
CancerAppy is a biotech company founded in 2019, specializing in cancer research. They focus on discovering and developing new therapeutic targets using a proprietary artificial intelligence methodology. Their platform analyzes vast amounts of multimodal data with advanced AI algorithms to identify new targets, discover lead compounds, understand mechanisms of action, and explore drug combinations. They also develop next-generation antibody-drug conjugates (ADCs) for more precise cancer treatments. CancerAppy operates in the early stage of the Drug Discovery Value Chain and offers consulting services in areas like target validation, inhibitor identification, and computer-aided drug design. Their mission is to translate scientific discoveries into clinical practice to improve cancer diagnosis and treatment, aiming to become a global reference tool for scientists and drug developers.